A SPAC II Acquisition Corporation
ASCB
NASDAQ Global Market11.19
USD
+11.19
- -
A SPAC II Acquisition Corporation
ASCB
(NASDAQ Global Market)
Recent
price
11.19
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- A SPAC II Acquisition Corp. is a blank check company incorporated in the British Virgin Islands on June 28, 2021, and headquartered at 289 Beach Road #03-01, Singapore 199552; its securities trade over-the-counter under the symbols ASCBF, ASCWF and ASCRF following delisting from Nasdaq in September 2024. The company has no significant operations or revenues and focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, targeting high-growth industries applying cutting-edge technologies such as Proptech and Fintech, with a preference for companies promoting environmental, social and governance (ESG) principles; it pursues targets primarily in North America, Europe and Asia (excluding Mainland China, Hong Kong and Macau). A subsidiary of A SPAC II (Holdings) Corp., it completed a $200 million initial public offering of 20 million units on May 5, 2022, each comprising one Class A ordinary share, one-half redeemable warrant and one right to one-tenth of a Class A ordinary share, alongside a private placement of 8.966 million warrants to its sponsor. In recent developments, shareholders approved charter amendments at extraordinary general meetings on August 1, 2023, and July 23, 2024, extending the business combination deadline to August 5, 2025 (up to 39 months post-IPO), with significant redemptions of 18 million and 1.6 million Class A shares respectively; the sponsor exchanged 4.9 million Class B shares for Class A shares in December 2023 to address market value compliance issues, and the company received non-compliance notices from Nasdaq in December 2023 and March 2024 before trading suspension and transition to OTC markets. Led by CEO Serena Shie and CFO Claudius Tsang, with an experienced board including Independent Non-executive Chairman Malcolm F. MacLean IV, the company continues to seek suitable acquisition opportunities amid ongoing extensions and regulatory adjustments.